Webinar: Is Immuno-Oncology A Bubble?
This article was originally published in Scrip
Executive Summary
Right now "we are not at the peak in immunotherapy but really at the base:" so says Sandip Patel, MD, Assistant Professor at UC San Diego Moores Cancer Center in a webinar recorded with Scrip West Coast Editor Mandy Jackson and Robert Jeng, senior scientific analyst at BioMedTracker.
You may also be interested in...
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.